SC
PFE icon

Sculptor Capital’s Pfizer PFE Stock Holding History

Sculptor Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-12,950,393
Closed -$364M – 382
2016
Q1 		$364M Buy
+12,950,393
New +$370M 1.85% 10
2015
Q1 		– Sell
-450,901
Closed -$13.3M – 680
2014
Q4 		$13.3M Sell
450,901
-7,065,173
-94% -$203M 0.04% 313
2014
Q3 		$211M Sell
7,516,074
-9,037,628
-55% -$254M 0.61% 48
2014
Q2 		$466M Buy
16,553,702
+3,661,490
+28% +$104M 1.39% 8
2014
Q1 		$393M Buy
12,892,212
+2,005,024
+18% +$59.8M 1.29% 16
2013
Q4 		$316M Buy
10,887,188
+333,591
+3% +$9.71M 0.81% 22
2013
Q3 		$288M Buy
10,553,597
+6,768,051
+179% +$184M 0.82% 22
2013
Q2 		$101M Buy
+3,785,546
New +$105M 0.32% 97

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sculptor Capital's PFE Position: Q2 2016 in Review

Sculptor Capital sold out of Pfizer (PFE) in Q2 2016, closing a stake of 952,078 shares — an estimated $26.8M sold.

Sculptor Capital first reported a position in PFE in Q3 2013 and held it in 8 quarters. The position peaked at $197M in Q2 2014. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • Sculptor Capital reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
  • Sculptor Capital sold 952,078 Pfizer shares in Q2 2016, an estimated $26.8M.
  • Sculptor Capital first reported a position in Pfizer in Q3 2013 and held it in 8 quarters.
  • Sculptor Capital's Pfizer position peaked at $197M in Q2 2014.
  • 1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Sculptor Capital's 13F filing for Q2 2016, filed 15 Aug 2016.